174 related articles for article (PubMed ID: 19706714)
1. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.
Vendrame D; Sourisseau M; Perrin V; Schwartz O; Mammano F
J Virol; 2009 Oct; 83(20):10527-37. PubMed ID: 19706714
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
Smith MS; Thresher RJ; Pagano JS
Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
[TBL] [Abstract][Full Text] [Related]
4. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
5. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
[TBL] [Abstract][Full Text] [Related]
6. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
[TBL] [Abstract][Full Text] [Related]
7. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
Agy MB; Acker RL; Sherbert CH; Katze MG
Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
[TBL] [Abstract][Full Text] [Related]
8. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
[TBL] [Abstract][Full Text] [Related]
9. Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs.
Tan J; Wang X; Devadas K; Zhao J; Zhang P; Hewlett I
J Cell Physiol; 2013 Dec; 228(12):2305-13. PubMed ID: 23696271
[TBL] [Abstract][Full Text] [Related]
10. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
[TBL] [Abstract][Full Text] [Related]
11. A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.
Thippeshappa R; Ruan H; Wang W; Zhou P; Kimata JT
J Virol; 2013 Jun; 87(12):6678-92. PubMed ID: 23552412
[TBL] [Abstract][Full Text] [Related]
12. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
Hansen BD; Nara PL; Maheshwari RK; Sidhu GS; Bernbaum JG; Hoekzema D; Meltzer MS; Gendelman HE
J Virol; 1992 Dec; 66(12):7543-8. PubMed ID: 1279206
[TBL] [Abstract][Full Text] [Related]
13. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2.
Dern K; Rübsamen-Waigmann H; Unger RE
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):295-309. PubMed ID: 11242517
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
16. Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes.
Veres G; Escaich S; Baker J; Barske C; Kalfoglou C; Ilves H; Kaneshima H; Böhnlein E
J Virol; 1996 Dec; 70(12):8792-800. PubMed ID: 8971008
[TBL] [Abstract][Full Text] [Related]
17. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.
Palmer BE; Boritz E; Blyveis N; Wilson CC
J Virol; 2002 Jun; 76(12):5925-36. PubMed ID: 12021325
[TBL] [Abstract][Full Text] [Related]
18. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
[TBL] [Abstract][Full Text] [Related]
19. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
Yu J; Liang C; Liu SL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
[TBL] [Abstract][Full Text] [Related]
20. Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects.
Eyeson J; King D; Boaz MJ; Sefia E; Tomkins S; Waters A; Easterbrook PJ; Vyakarnam A
AIDS; 2003 Nov; 17(16):2299-311. PubMed ID: 14571181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
